Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AFFYMETRIX (AFFX) -- Ignore unavailable to you. Want to Upgrade?

To: Randy Ellingson who wrote (712)	6/3/1998 5:35:00 PM
From: jabbo	Read Replies (1) \| Respond to of 1728

It should be the latest one. There is active discussion on it in the Yahoo thread. They point to some errors. I have taken the initative to email the company in this regards... but not response yet. Of course I will forward it in both threads... jabbo.

To: Randy Ellingson who wrote (712)	6/9/1998 8:53:00 PM
From: Doug (Htfd,CT)	Read Replies (1) \| Respond to of 1728

The bearish Forbes article is in the June 15 issue and is online at forbes.com It is complimentary of Zaffaroni's past history, but raises skepticism that he can pull off a coup the third time, in competition with Synteni, which may have a lower cost structure. The article concludes: "It is highly probable that DNA chips will be a godsend to medicine. It's not clear that this godsend will drop to Affymetrix's bottom line. " Doug (no position in AFFX)